Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.pastori@uniroma1.it
Daniele Pastori
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
daniele.pastori@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. the ARAPACIS Study
THROMBOSIS AND HAEMOSTASIS
2016
Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke"
INTERNATIONAL JOURNAL OF CARDIOLOGY
2016
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2016
Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies
HIV MEDICINE
2016
Ridotta attività della lipasi acida lisosomiale: un possibile ruolo patogenetico nella nafld?
GIORNALE ITALIANO DELL'ARTERIOSCLEROSI
2016
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding
PHARMACOLOGICAL RESEARCH
2016
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia
JOURNAL OF INFECTION
2016
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2016
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality"
ATHEROSCLEROSIS
2016
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients?
ANTIOXIDANTS & REDOX SIGNALING
2016
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2016
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation
ONCOTARGET
2016
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease
INTERNATIONAL JOURNAL OF CARDIOLOGY
2016
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE
2016
Interaction between dietary Vitamin K intake and anticoagulation by Vitamin K antagonists: is it really true?: A systematic review
MEDICINE
2016
HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity.
JOURNAL OF INFECTION
2015
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation
THROMBOSIS AND HAEMOSTASIS
2015
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
DIGESTIVE AND LIVER DISEASE
2015
Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation
INTERNATIONAL JOURNAL OF CARDIOLOGY
2015
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.
INTERNATIONAL JOURNAL OF CARDIOLOGY
2015
« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »
ERC
LS4
LS4_10
LS7
LS7_10
Keywords
cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis
Progetti di Ricerca
Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma